176 related articles for article (PubMed ID: 28092099)
21. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
Park SK; Sanders BG; Kline K
Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
[TBL] [Abstract][Full Text] [Related]
22. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.
Day TW; Huang S; Safa AR
Biochem Pharmacol; 2008 Dec; 76(12):1694-704. PubMed ID: 18840411
[TBL] [Abstract][Full Text] [Related]
23. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
[TBL] [Abstract][Full Text] [Related]
24. Activating Transcription Factor 4 (ATF4)-ATF3-C/EBP Homologous Protein (CHOP) Cascade Shows an Essential Role in the ER Stress-Induced Sensitization of Tetrachlorobenzoquinone-Challenged PC12 Cells to ROS-Mediated Apoptosis via Death Receptor 5 (DR5) Signaling.
Liu Z; Shi Q; Song X; Wang Y; Wang Y; Song E; Song Y
Chem Res Toxicol; 2016 Sep; 29(9):1510-8. PubMed ID: 27484784
[TBL] [Abstract][Full Text] [Related]
25. STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1.
Jiang Y; Yu M; Hu X; Han L; Yang K; Ba H; Zhang Z; Yin B; Yang XP; Li Z; Wang J
Cell Death Differ; 2017 Apr; 24(4):660-671. PubMed ID: 28186502
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
27. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
28. PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.
Yuan K; Sun Y; Zhou T; McDonald J; Chen Y
Clin Cancer Res; 2013 Sep; 19(17):4750-9. PubMed ID: 23833311
[TBL] [Abstract][Full Text] [Related]
29. Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function.
Oh YT; Qian G; Deng J; Sun SY
Oncogene; 2018 Jun; 37(25):3415-3425. PubMed ID: 29551769
[TBL] [Abstract][Full Text] [Related]
30. Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.
Fernandez TF; Samal AB; Bedwell GJ; Chen Y; Saad JS
J Biol Chem; 2013 Jul; 288(30):21898-908. PubMed ID: 23760276
[TBL] [Abstract][Full Text] [Related]
31. Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.
Das S; Tripathi N; Siddharth S; Nayak A; Nayak D; Sethy C; Bharatam PV; Kundu CN
Apoptosis; 2017 Oct; 22(10):1205-1224. PubMed ID: 28702823
[TBL] [Abstract][Full Text] [Related]
32. Conformation and free energy analyses of the complex of calcium-bound calmodulin and the Fas death domain.
Suever JD; Chen Y; McDonald JM; Song Y
Biophys J; 2008 Dec; 95(12):5913-21. PubMed ID: 18820240
[TBL] [Abstract][Full Text] [Related]
33. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.
Ouyang W; Yang C; Zhang S; Liu Y; Yang B; Zhang J; Zhou F; Zhou Y; Xie C
Int J Oncol; 2013 Feb; 42(2):699-711. PubMed ID: 23258590
[TBL] [Abstract][Full Text] [Related]
34. ADAM15 in Apoptosis Resistance of Synovial Fibroblasts: Converting Fas/CD95 Death Signals Into the Activation of Prosurvival Pathways by Calmodulin Recruitment.
Janczi T; Böhm BB; Fehrl Y; DeGiacomo P; Kinne RW; Burkhardt H
Arthritis Rheumatol; 2019 Jan; 71(1):63-72. PubMed ID: 30003689
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway.
Gopalan A; Yu W; Sanders BG; Kline K
Cancer Lett; 2013 Feb; 329(1):9-16. PubMed ID: 22960596
[TBL] [Abstract][Full Text] [Related]
36. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
Jayasooriya RG; Choi YH; Hyun JW; Kim GY
Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin couples death receptors to the cytoskeleton to regulate apoptosis.
Lu M; Marsters S; Ye X; Luis E; Gonzalez L; Ashkenazi A
Mol Cell; 2014 Jun; 54(6):987-998. PubMed ID: 24882208
[TBL] [Abstract][Full Text] [Related]
38. β-elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts.
Xu L; Guo T; Qu X; Hu X; Zhang Y; Che X; Song H; Gong J; Ma R; Li C; Fan Y; Ma Y; Hou K; Wu P; Dong H; Liu Y
Cell Biol Int; 2018 Sep; 42(10):1377-1385. PubMed ID: 29957841
[TBL] [Abstract][Full Text] [Related]
39. A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.
Kim H; Buchsbaum DJ; Zinn KR
Mol Imaging Biol; 2016 Jun; 18(3):325-33. PubMed ID: 26552657
[TBL] [Abstract][Full Text] [Related]
40. Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
Oliver PG; LoBuglio AF; Zhou T; Forero A; Kim H; Zinn KR; Zhai G; Li Y; Lee CH; Buchsbaum DJ
Breast Cancer Res Treat; 2012 Jun; 133(2):417-26. PubMed ID: 21901385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
